Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/1996
12/27/1996EP0749477A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
12/27/1996EP0749476A1 Mediators of chronic allograft rejection
12/27/1996EP0749444A1 Hybrid human/animal factor viii
12/27/1996EP0749442A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES
12/27/1996EP0749436A1 Compositions and methods for use in the synthesis of oligonucleotides
12/27/1996EP0749322A1 VACUOLATING TOXIN-DEFICIENT $i(H. PYLORI) AND RELATED METHODS
12/27/1996EP0749312A1 $i(DIROFILARIA IMMITIS) Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF
12/27/1996EP0664833B1 Therapeutic anti-hiv oligonucleotide and pharmaceutical
12/27/1996CA2607563A1 Magnetic particles with a glass surface and their use
12/27/1996CA2605671A1 Magnetic particles with a glass surface and their use
12/25/1996CN1138588A Phosphonomonoester nucleic acids, process for their preparation, and their use
12/24/1996US5587480 Treating hiv and hepatitis virus infections
12/24/1996US5587478 Sapphyrin multimers
12/24/1996US5587472 Fluorescent label
12/24/1996US5587471 Analyzing and evaluating phosphorus bearing monomeric units as to their suitability, coupling efficiency, in preparing random oligomer libraries; combinatorial chemistry
12/24/1996US5587470 3-deazapurines
12/24/1996US5587469 Oligonucleotides containing N-2 substituted purines
12/24/1996US5587468 High affinity nucleic acid ligands to HIV integrase
12/24/1996US5587371 Effective for treating hypoxic areas of solid neoplasms
12/24/1996US5587362 L-nucleosides
12/24/1996US5587361 Oligonucleotides having phosphorothioate linkages of high chiral purity
12/21/1996CA2169201A1 Lactic bacteria producing exopolysaccharides
12/19/1996WO1996041197A1 Adduct protection assay
12/19/1996WO1996041019A1 Use of nucleic acid ligands in flow cytometry
12/19/1996WO1996041011A1 Oligonucleotide tags for sorting and identification
12/19/1996WO1996041009A1 Residues for binding third strands to complementary nucleic acid duplexes of any base pair sequence
12/19/1996WO1996041006A1 Modified nucleotides for nucleic acid labeling
12/19/1996WO1996040991A1 Enzyme linked oligonucleotide assays (elonas)
12/19/1996WO1996040977A1 Origin of replication complex genes
12/19/1996WO1996040935A1 Recombinant hexose oxidase, a method of producing same and use of such enzyme
12/19/1996WO1996040898A1 Triple-helix forming oligonucleotides for targeted mutagenesis
12/19/1996WO1996040719A1 Endothelial-monocyte activating polypeptide iii
12/19/1996WO1996040712A1 Nucleic acid mediated electron transfer
12/19/1996WO1996040711A1 Cross-linking oligonucleotides
12/19/1996WO1996040710A1 Triplex-forming antisense oligonucleotides having abasic linkers targeting nucleic acids comprising mixed sequences of purines and pyrimidines
12/19/1996WO1996040709A1 Pna-dna chimeras and pna synthons for their preparation
12/19/1996WO1996040708A2 Improved methods for oligonucleotide synthesis
12/19/1996WO1996040672A1 Combinatorial libraries having aminodiol monomer subunits
12/19/1996WO1996040273A2 Conjugates of ferrites and oligonucleotides, which bond specifically to certain target structures
12/19/1996WO1996040266A1 Method of treatment for asthma
12/19/1996WO1996040265A1 Stabilization of polynucleotide complexes
12/19/1996WO1996040253A2 Rna photocleavage using texaphyrins
12/19/1996WO1996040159A1 Capped synthetic rna, analogs, and aptamers
12/19/1996WO1996040059A1 Dinucleotides useful for the treatment of lung disease
12/19/1996WO1996039841A1 Tumor- or cell-specific herpes simplex virus replication
12/19/1996CA2332731A1 Oligonucleotide tags for sorting and identification
12/19/1996CA2223921A1 Stabilization of polynucleotide complexes
12/19/1996CA2223584A1 Crosslinking oligonucleotides
12/19/1996CA2223549A1 Capped synthetic rna, analogs, and aptamers
12/19/1996CA2222440A1 Improved methods for oligonucleotide synthesis
12/19/1996CA2221821A1 Endothelial-monocyte activating polypeptide iii
12/18/1996EP0748871A1 Phage-resistant streptococcus
12/18/1996EP0748870A2 Oncostatin M induced hematopoiesis
12/18/1996EP0748868A2 Ceramide glucosyltransferase
12/18/1996EP0748806A1 POLYMORPHS B AND C OF 1- 2,4-DICHLORO-BETA-[(7-CHLOROBENZO[b]THIEN-3-YL)METHOXY]PHENETYL]IMIDAZOLE MONONITRATE
12/18/1996EP0748390A1 Comparative gene transcript analysis
12/18/1996EP0748383A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
12/18/1996EP0748382A1 Non-nucleotide containing enzymatic nucleic acid
12/18/1996EP0748380A1 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID $g(b)-PROTEIN PRECURSOR INHIBITOR
12/18/1996EP0748376A1 Rna editing enzyme and methods of use thereof
12/18/1996EP0748374A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
12/18/1996EP0748331A1 Modified oligonucleotide duplexes having anticancer activity
12/18/1996EP0748330A1 L-nucleosides for the treatment of hepatitis b-virus and epstein-bar virus
12/18/1996EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
12/18/1996CN1138295A A novel tumor suppressor gene
12/18/1996CN1138047A Method for preparing antisense oligo-deoxy'nucleotide by using recombinant plasmid
12/17/1996US5585481 Linking reagents for nucleotide probes
12/17/1996US5585477 Nucleic acid in kit for amplification and diagnosis of polio
12/17/1996US5585356 Matrix metalloproteinase peptides: role in diagnosis and therapy
12/17/1996US5585247 Fluorogenic compounds and their use
12/17/1996US5585242 Method for detection of nucleic acid using total internal reflectance
12/17/1996US5585236 Ion-pair reverse phase chromatography
12/17/1996US5585096 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
12/17/1996CA2178975A1 Phages resistant streptococcus
12/17/1996CA1338800C Hepatitis delta and diagnostics and vaccines
12/12/1996WO1996039537A1 Amplification of nucleic acid sequences
12/12/1996WO1996039515A1 Human vascular endothelial growth factor 2
12/12/1996WO1996039497A1 Transforming growth factor alpha hi
12/12/1996WO1996039417A1 Chemical, biochemical and biological processing in thin films
12/12/1996WO1996039415A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION
12/12/1996WO1996039414A1 Novel base protecting groups for oligonucleotide synthesis
12/12/1996WO1996039413A1 Methods and compounds for the synthesis of oligonucleotides and the oligonucleotides thereby produced
12/12/1996WO1996039195A2 Chemically modified oligonucleotide for site-directed mutagenesis
12/12/1996WO1996039154A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
12/12/1996WO1996039152A1 Use of locally applied dna fragments
12/12/1996WO1996018638A3 2'-o-derivatized pyrimidine ribonucleosides and methods of production
12/12/1996DE19611376A1 Nucleic acid cpds. contg. non-nucleic acid ring skeleton, pref. tri:terpenoid
12/12/1996DE19520398A1 Magnetic particles with, opt. porous, glass surface
12/12/1996CA2562211A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2562162A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2413012A1 Human vascular endothelial growth factor 2
12/12/1996CA2223957A1 Transforming growth factor alpha hi
12/12/1996CA2223496A1 Chemical, biochemical and biological processing in thin films
12/12/1996CA2223103A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
12/12/1996CA2216912A1 Human g-protein chemokine receptor hdgnr10
12/11/1996EP0747706A1 Adduct protection assay
12/11/1996EP0747483A2 Fermentative carotenoid production
12/11/1996EP0747482A2 Hepatitis GB virus recombinant proteins and uses thereof
12/11/1996EP0747481A1 Epstein-Barr virus peptides and antibodies against these peptides
12/11/1996EP0746619A1 Human phosphodiesterase type ivc, and its production and use